An internal standard for the quantification of medetomidine
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Medetomidine-13C-d3 (hydrochloride)

Item No. 25041

Technical Information
Formal Name
5-(1-(2,3-dimethylphenyl)ethyl-2-13C-2,2,2-d3)-1H-imidazole, monohydrochloride
CAS Number
1216630-06-6
Synonyms
  • MVP 785-13C-d3
Molecular Formula
C12[13C]H13D3N2 • HCl
Formula Weight
Purity
≥99% deuterated forms (d1-d3)
Formulation
A solid
Methanol: Slightly soluble
SMILES
CC1=C(C)C(C([13C]([2H])([2H])[2H])C2=CN=CN2)=CC=C1.Cl
InChi Code
InChI=1S/C13H16N2.ClH/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13;/h4-8,11H,1-3H3,(H,14,15);1H/i3+1D3;
InChi Key
VPNGEIHDPSLNMU-RWALGPICSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Product Description

    Medetomidine-13C-d3 is intended for use as an internal standard for the quantification of medetomidine (Item No. 16454) by GC- or LC-MS. Medetomidine is an agonist of α2-adrenergic receptors (α2-ARs; Ki = 1.08 nM).1 It is selective for α2-ARs over α1-ARs (Ki = 1,750 nM). Medetomidine induces sedation in dogs.2 Formulations containing medetomidine have been used as sedatives in veterinary medicine.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Virtanen, R., Savola, J.M., Saano, V., et alCharacterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist. Eur. J. Pharmacol. 150(1-2), 9-14 (1988).

    2. Vainio, O., and Vähä-Vahe, T. Reversal of medetomidine sedation by atipamezole in dogs. J. Vet. Pharmacol. Ther. 13(1), 15-22 (1990).